Considering CAR T-cell Therapy in Follicular Lymphoma

Host: Charles Turck, PharmD, BCPS, BCCCP <br> Guest: Elise Chong, MD <br> <p>Patients with follicular lymphoma who relapse or don’t respond to treatment don’t have many therapeutic options, but a recently FDA-approved CAR T-cell therapy may help change that. Dr. Charles Turck is joined by Dr. Elise Chong from Penn Medicine’s Abramson Cancer Center to explore this new treatment option.</p>